Social and geographical factors affecting access to treatment of lung cancer

被引：81

作者：

Crawford, S. M. ^{[1
]}

Sauerzapf, V. ^{[2
]}

Haynes, R. ^{[2
]}

Zhao, H. ^{[2
,3
]}

Forman, D. ^{[4
,5
,6
]}

Jones, A. P. ^{[2
]}

机构：

[1] Airedale Dist Gen Hosp, Keighley BD20 6TD, W Yorkshire, England

[2] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England

[3] Hlth Protect Agcy, Resp & Syst Infect Dept, Ctr Infect, London NW9 5EQ, England

[4] Univ Leeds, Ctr Biostat & Epidemiol, Leeds LS9 7TF, W Yorkshire, England

[5] St James Univ Hosp, No & Yorkshire Canc Registry, St Jamess Inst Oncol, Leeds LS9 7TF, W Yorkshire, England

[6] St James Univ Hosp, Informat Serv, St Jamess Inst Oncol, Leeds LS9 7TF, W Yorkshire, England

来源：

BRITISH JOURNAL OF CANCER | 2009年 / 101卷 / 06期

关键词：

lung cancer; socioeconomic factors; distance; travel; thoracic surgery; histopathology; DIAGNOSIS; SURVIVAL; INEQUALITIES; ENGLAND; CHEMOTHERAPY; STAGE;

D O I：

10.1038/sj.bjc.6605257

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

BACKGROUND: UK residents' healthcare is free of charge but uptake varies. Cancer survival is inferior to that of other Western European countries. We have used cancer registry data to assess factors associated with access to diagnosis and treatment of lung cancer in northern England. METHOD: We assigned 34 923 lung cancer patients diagnosed between 1994 and 2002 to quartiles for the deprivation score associated with their postcode and for the travel time to the relevant healthcare facility. Odds ratios, adjusted for age and sex, for undergoing interventions were calculated relative to the least deprived quartile living closest to the facility. The odds ratio for receiving chemotherapy for small-cell lung cancer (SCLC) was calculated according to the type of hospital where it was diagnosed. RESULTS: The odds ratio for attainment of a histological diagnosis for the least deprived/furthest residence group was 0.83 (95% confidence 0.70-0.97) for the most deprived/nearest residence group was 0.74(0.62-0.87) and for the most deprived/furthest residence group it was 0.61 (0.49-0.75). The corresponding odds ratios for receipt of any active treatment were 0.93 (0.80-1.07), 0.74 (0.64-0.86), and 0.55 (0.46-0.67). The odds ratios for receipt of chemotherapy for SCLC were 1.27 (0.89-1.82), 1.21 (0.85-1.74) and 0.81 (0.52-1.28). Odds ratios for undergoing surgery for non-small cell lung cancer using (1) travel time to diagnosing hospital were 0.88 (0.70-1.11), 0.74 (0.59-0.94) and 0.60 (0.44-0.84). Using (2) travel time to a thoracic surgery facility they were 0.83 (0.65-1.06), 0.70 (0.55-0.89) and 0.55 (0.49-0.76). CONCLUSION: Living in a deprived locality reduces the likelihood of undergoing definitive management for lung cancer with the exception of chemotherapy for SCLC. This is amplified by travel time to services. British Journal of Cancer (2009) 101, 897-901. doi:10.1038/sj.bjc.6605257 www.bjcancer.com Published online 18 August 2009 (C) 2009 Cancer Research UK

引用

页码：897 / 901

页数：5

共 18 条

[1] Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study [J].

Berrino, Franco ;

De Angelis, Roberta ;

Sant, Milena ;

Rosso, Stefano ;

Lasota, Magdalena B. ;

Coebergh, Jan W. ;

Santaquilani, Mariano .

LANCET ONCOLOGY, 2007, 8 (09) :773-783

[2] Impact of deprivation and rural residence on treatment of colorectal and lung cancer [J].

Campbell, NC ;

Elliott, AM ;

Sharp, L ;

Ritchie, LD ;

Cassidy, J ;

Little, J .

BRITISH JOURNAL OF CANCER, 2002, 87 (06) :585-590

[3] Rural and urban differences in stage at diagnosis of colorectal and lung cancers [J].

Campbell, NC ;

Elliott, AM ;

Sharp, L ;

Ritchie, LD ;

Cassidy, J ;

Little, J .

BRITISH JOURNAL OF CANCER, 2001, 84 (07) :910-914

[4] LUNG-CANCER - HISTOLOGICAL ASPECTS OF DIAGNOSIS IN ENGLAND AND THE SOUTH EAST NETHERLANDS [J].

CRAWFORD, SM ;

ATHERTON, F .

JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1994, 48 (04) :420-421

[5]

Department of Health, 2000, NHS CANC PLAN

[6] Who gets chemotherapy for metastatic lung cancer? [J].

Earle, CC ;

Venditti, LN ;

Neumann, PJ ;

Gelber, RD ;

Weinstein, MC ;

Potosky, AL ;

Weeks, JC .

CHEST, 2000, 117 (05) :1239-1246

[7] Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis [J].

Halpern, Michael T. ;

Ward, Elizabeth M. ;

Pavluck, Alexandre L. ;

Schrag, Nicole M. ;

Bian, John ;

Chen, Amy Y. .

LANCET ONCOLOGY, 2008, 9 (03) :222-231

[8] What are the clinical features of lung cancer before the diagnosis is made? - A population based case-control study [J].

Hamilton, W ;

Peters, TJ ;

Round, A ;

Sharp, D .

THORAX, 2005, 60 (12) :1059-1065

[9] Validation of travel times to hospital estimated by GIS [J].

Haynes R. ;

Jones A.P. ;

Sauerzapf V. ;

Zhao H. .

International Journal of Health Geographics, 5 (1)

[10] Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to oncology services? [J].

Jack, RH ;

Gulliford, MC ;

Ferguson, J ;

Moller, H .

BRITISH JOURNAL OF CANCER, 2003, 88 (07) :1025-1031

← 1 2 →